Aurora Cannabis Q1 2025 Investor Call Set for August 14

Ticker: ACB · Form: 6-K · Filed: 2024-07-29T00:00:00.000Z

Sentiment: neutral

Topics: investor-relations, conference-call, earnings-announcement

Related Tickers: ACB

TL;DR

ACB investor call Aug 14 for Q1 2025 results.

AI Summary

Aurora Cannabis Inc. announced on July 29, 2024, that it will host its first quarter 2025 investor conference call on August 14, 2024. The call will discuss the company's financial results for the period ending June 30, 2024. Miguel Martin, CEO, signed the report.

Why It Matters

This announcement signals the upcoming release of Aurora Cannabis's financial performance for its first fiscal quarter of 2025, providing insights into the company's operational and financial health.

Risk Assessment

Risk Level: low — This filing is a routine announcement of an investor conference call date and does not contain new material financial information or strategic changes.

Key Players & Entities

FAQ

What is the purpose of this 6-K filing?

The purpose of this 6-K filing is to report that Aurora Cannabis Inc. will host its first quarter 2025 investor conference call on August 14, 2024, to discuss financial results for the period ending June 30, 2024.

When will Aurora Cannabis announce its Q1 2025 financial results?

Aurora Cannabis will announce its Q1 2025 financial results and host an investor conference call on August 14, 2024.

Who signed the Form 6-K filing?

The Form 6-K filing was signed by Miguel Martin, Chief Executive Officer of Aurora Cannabis Inc.

What period do the upcoming Q1 2025 results cover?

The upcoming Q1 2025 results will cover the period ending June 30, 2024.

Which stock exchanges is Aurora Cannabis listed on?

Aurora Cannabis is listed on NASDAQ and TSX, indicated by the ticker symbol ACB.

From the Filing

0001279569-24-000921.txt : 20240729 0001279569-24-000921.hdr.sgml : 20240729 20240729074029 ACCESSION NUMBER: 0001279569-24-000921 CONFORMED SUBMISSION TYPE: 6-K PUBLIC DOCUMENT COUNT: 3 CONFORMED PERIOD OF REPORT: 20240729 FILED AS OF DATE: 20240729 DATE AS OF CHANGE: 20240729 FILER: COMPANY DATA: COMPANY CONFORMED NAME: AURORA CANNABIS INC CENTRAL INDEX KEY: 0001683541 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: 6-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-38691 FILM NUMBER: 241148897 BUSINESS ADDRESS: STREET 1: 2207 90B STREET SW CITY: EDMONTON STATE: A0 ZIP: T6X 1V8 BUSINESS PHONE: 604-362-5207 MAIL ADDRESS: STREET 1: 409 GRANVILLE STREET STREET 2: SUITE 1700 CITY: VANCOUVER STATE: A1 ZIP: V6C 1T2 6-K 1 aurora_6k.htm FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of July 2024 Commission File No. 001-38691 AURORA CANNABIS INC. (Translation of registrant's name into English) 2207 90B St. SW Edmonton, Alberta T6X 1V8 Canada (Address of principal executive office) Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F Form 20-F ☐ Form 40-F ☒ SUBMITTED HEREWITH Exhibits Description 99.1 News Release dated July 29, 2024 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. AURORA CANNABIS INC. /s/ Miguel Martin Miguel Martin Chief Executive Officer Date: July 29, 2024 EX-99.1 2 ex991.htm NEWS RELEASE DATED JULY 29, 2024 Exhibit 99.1 Aurora Cannabis to Host First Quarter 2025 Investor Conference Call NASDAQ | TSX: ACB EDMONTON, AB, July 29, 2024 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), a leading Canada-based global medical cannabis company, announced today that it has scheduled a conference call to discuss the results for its first quarter 2025 on Wednesday, August 7, 2024 at 8:00 a.m. Eastern Time | 6:00 a.m. Mountain Time. The Company will report its financial results for the first quarter 2025 before the opening of markets that same day. Conference Call Details DATE: Wednesday, August 7, 2024 TIME: 8:00 a.m. Eastern Time | 6:00 a.m. Mountain Time WEBCAST: Click Here Miguel Martin, Chief Executive Officer, and Simona King, Chief Financial Officer, will host the conference call and question and answer period. This weblink has also been posted to the Company's "Investor Info" link at https://www.auroramj.com/investors/ under "Events". About Aurora Cannabis Aurora is opening the world to cannabis, serving both the medical and consumer markets across Canada, Europe, Australia and South America. Headquartered in Edmonton, Alberta, Aurora is a pioneer in global cannabis, dedicated to helping people improve their lives. The Company's adult- use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Tasty's, Being and Greybeard. Medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, Bidiol, IndiMed and CraftPlant. Aurora also has a controlling interest in Bevo Farms Ltd., North America's leading supplier of propagated agricultural plants. Driven by science and innovation, and with a focus on high-quality cannabis products, Aurora's brands continue to break through as industry leaders in the medical, wellness and adult recreational markets wherever they are launched. Learn more at www.aurora. Learn more at www.auroramj.com and follow us on X and LinkedIn. Aurora's

View on Read The Filing